These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38956614)

  • 21. Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?
    Beck EJ; Mandalia S; DongmoNguimfack B; Pinheiro E; 't Hoen E; Boulet P; Stover J; Gupta A; Juneja S; Habiyambere V; Ghys P; Nunez C
    Glob Health Action; 2019; 12(1):1586317. PubMed ID: 30983547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
    Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P
    BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding Licensure Portability And Access To Care: Lessons Learned During COVID-19.
    Chaudhry HJ
    Health Aff (Millwood); 2022 Aug; 41(8):1136-1138. PubMed ID: 35914196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for understanding generic procurement of HIV medicines by developing countries with patent protection.
    Beall RF; Attaran A
    Soc Sci Med; 2017 Jul; 185():118-126. PubMed ID: 28578209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis.
    Simmons B; Cooke GS; Miraldo M
    Lancet Glob Health; 2019 Sep; 7(9):e1189-e1196. PubMed ID: 31362914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.
    Gore C; Morin S; Røttingen JA; Kieny MP
    BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37669799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
    Assefa Y; Hill PS; Ulikpan A; Williams OD
    Global Health; 2017 Sep; 13(1):73. PubMed ID: 28903757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.
    Son KB
    Global Health; 2019 Jun; 15(1):42. PubMed ID: 31248441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B
    Pharm Pat Anal; 2012 Nov; 1(5):555-75. PubMed ID: 24236925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical new product development: the increasing role of in-licensing.
    Edwards NV
    Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways.
    Crager SE
    Am J Public Health; 2014 Nov; 104(11):e85-91. PubMed ID: 25211753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.
    Waning B; Diedrichsen E; Moon S
    J Int AIDS Soc; 2010 Sep; 13():35. PubMed ID: 20840741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
    Son KB; Lee TJ
    Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waiving intellectual property rights: Boom or bust for medical innovation?
    Rake B
    Drug Discov Today; 2022 Feb; 27(2):384-389. PubMed ID: 34718204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways].
    Crager SE
    Rev Panam Salud Publica; 2015 Jan; 37(1):59-68. PubMed ID: 25791189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
    Adekola TA
    Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
    Global Burden of Disease 2021 Health Financing Collaborator Network
    Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of COVID-19 on diet quality, food security and nutrition in low and middle income countries: A systematic review of the evidence.
    Picchioni F; Goulao LF; Roberfroid D
    Clin Nutr; 2022 Dec; 41(12):2955-2964. PubMed ID: 34535329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
    Kuek V; Phillips K; Kohler JC
    Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
    Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.